Literature DB >> 20023895

The mechanism of action of platinum anticancer agents--what do we really know about it?

Dan Gibson1.   

Abstract

Although 40 years have passed since the discovery of the anticancer activity of cisplatin, the mechanism of action of the drug is unclear. There are several working hypotheses that guide the researchers in this field. Unexpected results that we obtained cannot be reconciled with some of those assumptions. Our main intention is to call upon researchers in the field to re-examine the working hypotheses that may have been formulated on the basis of outdated methodologies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20023895     DOI: 10.1039/b918871c

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  38 in total

1.  Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure-activity relationship modeling.

Authors:  Paola Gramatica; Ester Papa; Mara Luini; Elena Monti; Marzia B Gariboldi; Mauro Ravera; Elisabetta Gabano; Luca Gaviglio; Domenico Osella
Journal:  J Biol Inorg Chem       Date:  2010-06-06       Impact factor: 3.358

2.  The trans influence in the modulation of platinum anticancer agent biology: the effect of nitrite leaving group on aquation, reactions with S-nucleophiles and DNA binding of dinuclear and trinuclear compounds.

Authors:  Eva I Montero; Junyong Zhang; Joseph J Moniodis; Susan J Berners-Price; Nicholas P Farrell
Journal:  Chemistry       Date:  2010-08-09       Impact factor: 5.236

3.  Molecular and statistical modeling of reduction peak potential and lipophilicity of platinum(IV) complexes.

Authors:  James A Platts; Giuseppe Ermondi; Giulia Caron; Mauro Ravera; Elisabetta Gabano; Luca Gaviglio; Giorgio Pelosi; Domenico Osella
Journal:  J Biol Inorg Chem       Date:  2010-11-16       Impact factor: 3.358

4.  Titanocene-phosphine derivatives as precursors to cytotoxic heterometallic TiAu2 and TiM (M = Pd, Pt) compounds. Studies of their interactions with DNA.

Authors:  Jose F González-Pantoja; Michael Stern; Andrzej A Jarzecki; Eva Royo; Elisa Robles-Escajeda; Armando Varela-Ramírez; Renato J Aguilera; María Contel
Journal:  Inorg Chem       Date:  2011-09-29       Impact factor: 5.165

Review 5.  Redox activation of metal-based prodrugs as a strategy for drug delivery.

Authors:  Nora Graf; Stephen J Lippard
Journal:  Adv Drug Deliv Rev       Date:  2012-01-25       Impact factor: 15.470

6.  In vitro and in vivo antitumor activities and DNA binding mode of five coordinated cyclometalated organoplatinum(II) complexes containing biphosphine ligands.

Authors:  Michael Frezza; Q Ping Dou; Yan Xiao; Hamidreza Samouei; Mehdi Rashidi; Fayezeh Samari; Bahram Hemmateenejad
Journal:  J Med Chem       Date:  2011-08-24       Impact factor: 7.446

7.  Effect of in vivo post-translational modifications of the HMGB1 protein upon binding to platinated DNA: a molecular simulation study.

Authors:  Wenping Lyu Lv; Fabio Arnesano; Paolo Carloni; Giovanni Natile; Giulia Rossetti
Journal:  Nucleic Acids Res       Date:  2018-12-14       Impact factor: 16.971

8.  Synthesis, characterization, and cytotoxicity of platinum(IV) carbamate complexes.

Authors:  Justin J Wilson; Stephen J Lippard
Journal:  Inorg Chem       Date:  2011-03-01       Impact factor: 5.165

9.  Elusive Intermediates in the Breakdown Reactivity Patterns of Prodrug Platinum(IV) Complexes.

Authors:  Davide Corinti; Maria Elisa Crestoni; Simonetta Fornarini; Fortuna Ponte; Nino Russo; Emilia Sicilia; Elisabetta Gabano; Domenico Osella
Journal:  J Am Soc Mass Spectrom       Date:  2019-04-12       Impact factor: 3.109

Review 10.  Combination of nitric oxide and drug delivery systems: tools for overcoming drug resistance in chemotherapy.

Authors:  Jihoon Kim; Bryant C Yung; Won Jong Kim; Xiaoyuan Chen
Journal:  J Control Release       Date:  2016-12-26       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.